HIV-1 Protease
Company
Veritas, Incorporated
Use
Research reagent employed in developing treatments for Human Immunodeficiency Virus
Features
One of the most important targets for developing an anti-HIV-1 drug
NIH Contribution
Utilizing recombinant methods to produce highly purified HIV-1 protease in bacteria
HHS Institute/Agency
NIAMS
Inventor(s)
S. Stahl and P. Wingfield
Year
2000
Tech Cat
Research Reagent
